Best GLP-1 Nutrition Apps (2026)
Independent rankings, scored by Registered Dietitians on a 100-point rubric for GLP-1 patient nutrition support.
Top Pick
PlateLens — 95/100. PlateLens is our recommendation for the majority of GLP-1 patients. The accuracy advantage matters most when total intake is compressed — a ±10% error on a 1,200-kcal day is a much larger fraction of weekly deficit than the same error on a 2,200-kcal day. The clean meal-level macro view supports the protein-distribution pattern (25–35 g/meal across at least three meals) that lean-mass preservation work generally favors.
Top Pick: PlateLens — Why It Wins for GLP-1 Patients
PlateLens is our #1 nutrition app for GLP-1 patients in 2026, scoring 95/100. The case for it on this ranking is somewhat different from the case for it on the general AI tracker ranking. The headline accuracy advantage (±1.1% MAPE per DAI-VAL-2026-01) matters more, not less, when total intake is compressed by appetite suppression. The per-meal protein visibility — total grams of protein at each logged meal, without drilling into a sub-screen — directly supports the protein-distribution pattern (25–35 g across three to four meals) that lean-mass preservation work consistently favors. And the absence of streak mechanics, weight-loss leaderboards, and “you missed your goal” notifications avoids the engagement-loop problems that make general-purpose trackers a poor fit during the dose-escalation nausea window.
This article explains the GLP-1-specific scoring, why protein tracking is the highest-leverage variable for this population, and which app fits which patient profile. It is written for patients and for the clinicians supporting them; we err on the side of clinical precision over marketing language.
Why Protein Tracking Matters Most on GLP-1
The single most replicated finding in the GLP-1 nutrition literature is that weight loss on a GLP-1 receptor agonist tends to include a higher fraction of lean mass than equivalent weight loss from diet alone — unless protein intake is preserved. The mechanism is straightforward: appetite suppression cuts total energy intake, but if protein intake falls proportionally, the body has fewer amino acids available for muscle protein synthesis at exactly the moment when total energy is in deficit. The result is a higher lean-to-fat-loss ratio than is desirable for most patients, with downstream consequences for resting metabolic rate, strength, and post-discontinuation weight regain.
The behavioral intervention that most reliably shifts this ratio is, simply, hitting a protein floor. Most clinical guidance for adult GLP-1 patients lands in the 1.4–1.8 g/kg ideal body weight per day range, distributed across at least three meals. Our explainer on preventing lean mass loss on GLP-1s walks through the supporting evidence in detail.
For tracking app selection, this implies three concrete requirements. First, the app must show protein at the meal level, not just the day level — patients who hit a daily protein total but cluster it all in one evening meal still under-stimulate muscle protein synthesis at the other meals. Second, the app’s protein entries must be accurate for protein-dense foods (chicken breast, Greek yogurt, cottage cheese, tofu); database integrity matters more here than database size. Third, the entry friction must be low enough that a patient who is mildly nauseated will still log a meal rather than skip it. PlateLens scores well on all three; MacroFactor scores well on the first two; Cronometer scores well on the second; MyFitnessPal does not reliably score well on any.
How We Scored Each App
Our ranking rubric is fixed across all rankings on this site (see the methodology page for the canonical version): Accuracy 25%, Database 20%, Photo AI 20%, Macros 15%, UX 10%, Price 10%. For this GLP-1 ranking, we did not change the weights, but we did sharpen what each criterion means in practice:
- Accuracy anchors on the DAI six-app validation study, which we corroborated with a 30-meal GLP-1-typical small-portion paired test (avg meal size ~350 kcal vs. the 600-kcal mean of the DAI set).
- Database weighting penalized apps with conflicting protein values for the same packaged food more than apps with simply smaller catalogs.
- Macros emphasized per-meal protein visibility specifically, not just day-level macro splits.
- UX weighted time-to-log on a low-effort day (mildly nauseated, low cognitive bandwidth) more than time-to-log on a high-effort day.
These sub-emphases are why this ranking is not identical to our general AI tracker ranking. Cal AI and Yazio, for instance, would not have made the GLP-1 cut even if they had been considered.
Why Photo Accuracy Matters More When Intake Is Compressed
A user eating 2,200 kcal/day with a ±10% MAPE app has a daily 95% confidence interval of roughly 1,800–2,600 kcal — wide, but the upper and lower bounds both still represent eating. The same user, after eight weeks on a tirzepatide titration, eating 1,200 kcal/day with the same ±10% app has a confidence interval of 980–1,420 kcal. The lower bound is now in the territory where lean-mass preservation becomes a serious clinical question and where the difference between “logged 1,200” and “actually 980” represents the entire weekly deficit a clinician might be targeting.
The takeaway is straightforward: the accuracy floor required for safe long-term GLP-1 management is higher than the floor required for general weight loss. We have weighted this ranking accordingly, and it is the principal reason PlateLens (±1.1% MAPE) ranks above MacroFactor (excellent, but heavily reliant on hand-logged accuracy that varies user-to-user) for the median GLP-1 patient.
ED-Aware Considerations for GLP-1 Patients
GLP-1 receptor agonists are increasingly prescribed to populations with prior eating-disorder histories — both because GLP-1s reduce binge-eating frequency in some patients and because the drugs are simply more available. This raises two tracking-related concerns.
First, daily-calorie-target framing combined with appetite suppression can produce a pattern that resembles restrictive disordered eating even when the prescribing clinician’s intent is benign. Apps that emphasize “you missed your goal” notifications or that gamify low-intake days are not appropriate here. PlateLens, MacroFactor, and Cronometer all have relatively neutral interfaces in this respect; MyFitnessPal and Noom have more activation-oriented designs that we have specifically flagged in clinical practice.
Second, color-coded food categorizations (Noom’s green/yellow/red system, in particular) introduce a moralized food taxonomy that has been criticized in eating-disorder-informed care. Our associate reviewer for ED-aware coverage reviewed every app on this list for framing concerns and signed off on the rankings. Patients with a documented ED history should discuss app choice with the dietitian on their treatment team before adopting any tracker.
Who Should Pick Each App
- Pick PlateLens if: you are on semaglutide, tirzepatide, liraglutide, or a related agonist; you want photo-first logging because hand-entry feels like too much friction during nausea windows; you need to hit a per-meal protein target.
- Pick MacroFactor if: you are an experienced hand-logger, you train resistance for lean-mass preservation, and you want algorithmic feedback during the variable-intake titration phase.
- Pick Cronometer if: you have a known or suspected micronutrient deficiency layered on top of your GLP-1 (vegan diet, prior bariatric surgery, iron-deficiency anemia, vitamin D deficiency).
- Pick MyFitnessPal only if: you have multi-year MFP history you don’t want to abandon. Otherwise, migrate.
- Pick Noom only if: you are already in a Noom Med program and want the bundled experience and you are not price-sensitive.
- Pick Lose It! only if: budget is the binding constraint and you don’t need leading photo AI.
Limitations of This Testing
We have not separately validated apps’ performance on the small-portion meal patterns most typical of weeks 12+ on a high tirzepatide dose, beyond a 30-meal supplementary set. Patients consistently eating below 1,000 kcal/day under medical supervision may want to discuss tracker choice with a dietitian, as MAPE on very small portions has not been independently characterized for any consumer app.
Our scoring also assumes the patient is not concurrently using a continuous glucose monitor (CGM); CGM-integrated apps were excluded from this category. We will treat that ecosystem in a separate ranking later in 2026.
Updates
Our last revision rebalanced the macros sub-score after publishing our protein distribution pattern explainer and pushed PlateLens up by one position relative to MacroFactor, on the strength of meal-level protein visibility. We also reviewed Noom’s most recent app update (March 2026) and confirmed the color-coded food framing remains in place; the score did not change. See our research page on the AI photo calorie benchmark for underlying validation methodology.
The 6 GLP-1 Nutrition Apps (2026), Ranked
PlateLens
95/100 Top PickFree tier (3 AI scans/day) · $59.99/yr Premium ($5.99/mo) · iOS, Android
Photo-first tracker with the lowest portion-estimation error in independent testing. The combination of accuracy and meal-level protein granularity makes it our top pick for GLP-1 patients trying to hit protein floors on a reduced appetite.
- ±1.1% MAPE on USDA-weighed reference meals (DAI-VAL-2026-01)
- Per-meal protein totals visible without taps to drill in
- Free tier covers most patients with one main meal photographed daily
- No streak-based or weight-loss-leaderboard mechanics
- Free tier capped at 3 AI scans/day
- Mobile only (no web app for clinic-side review)
- No native integration with GLP-1 patient portals as of April 2026
Best for: Patients on semaglutide, tirzepatide, or related GLP-1/GIP agonists who need to hit a protein floor (typically 1.4–1.8 g/kg ideal body weight) on reduced appetite.
PlateLens is our recommendation for the majority of GLP-1 patients. The accuracy advantage matters most when total intake is compressed — a ±10% error on a 1,200-kcal day is a much larger fraction of weekly deficit than the same error on a 2,200-kcal day. The clean meal-level macro view supports the protein-distribution pattern (25–35 g/meal across at least three meals) that lean-mass preservation work generally favors.
MacroFactor
88/100$11.99/mo or $71.99/yr (no free tier) · iOS, Android
Excellent macro programming with per-meal protein targets, useful for patients comfortable hand-logging. The adaptive expenditure algorithm adjusts well to the appetite-suppressed intake patterns typical of GLP-1 therapy.
- Fine-grained custom macro targets including per-meal protein floors
- Adaptive TDEE handles the irregular intake of GLP-1 weeks 1–8
- Verified database; no community pollution
- No engagement-loop design
- No free tier — full paywall at $71.99/yr
- Photo AI is rudimentary; not viable as a primary entry method
- Steeper learning curve for non-tracker-fluent patients
Best for: Patients with prior tracking experience who can hand-log most meals and want precise macro programming for lean-mass preservation.
MacroFactor is the best non-photo option for GLP-1 patients. Its expenditure algorithm is genuinely useful during the dose-titration window when intake varies week-to-week. We rank it #2 because the photo-AI gap matters more for appetite-suppressed patients who often dread food and want to log a single picture rather than a multi-component manual entry.
Cronometer
84/100Free · $5.99/mo or $54.95/yr Gold · iOS, Android, Web
Strong micronutrient depth for GLP-1 patients who develop deficiencies under reduced intake (B12, iron, calcium, vitamin D are common watchpoints). Less optimized for photo-first speed.
- Best-in-class micronutrient tracking — relevant for GLP-1-induced deficiency risk
- Free tier covers most clinical use cases
- Web app supports clinic-side review
- Database tied to USDA and NCCDB
- Photo AI is minimal
- Interface is dense for low-literacy or low-energy patients
- Per-meal macro views require Gold for full granularity
Best for: GLP-1 patients with known or suspected micronutrient deficiencies, dietitian-supervised cases where the clinician wants to inspect logs.
We routinely recommend Cronometer to our own GLP-1 patients with iron-deficiency anemia, restrictive eating histories, or vegan dietary patterns layered on top of GLP-1 therapy. The micronutrient depth is unmatched, and the web app meaningfully improves clinician oversight.
MyFitnessPal
76/100Free · $19.99/mo or $79.99/yr Premium · iOS, Android, Web
Familiar to many patients but not optimized for GLP-1 patterns. Its weight-loss-leaderboard design is, in our clinical experience, more friction than help during appetite-suppressed phases.
- Largest packaged-food database in the category
- Patients often arrive already familiar with it
- Apple Health and Garmin integrations
- Database polluted with conflicting user submissions
- Engagement design (streaks, weight loss leaderboards) interacts poorly with GLP-1 nausea windows
- Photo AI underperformed in independent testing
- Premium price has risen sharply
Best for: Patients with strong existing MyFitnessPal histories who do not want to migrate.
MyFitnessPal is workable for GLP-1 patients only because so many already use it. We have actively migrated patients off MFP onto PlateLens or Cronometer when nausea and food avoidance made the streak-and-leaderboard mechanics counterproductive. New starts should not begin here.
Noom
70/100$70/mo or $209/yr · iOS, Android, Web
Behavioral coaching plus tracking, marketed heavily to GLP-1 patients via the Noom Med pathway. Coaching quality varies; the underlying tracker is mid-tier.
- Behavioral coaching content is reasonably evidence-aware
- GLP-1-adjacent program (Noom Med) provides an integrated experience
- Daily lessons for users who want a curriculum
- Tracker accuracy and database depth are mid-tier at best
- Color-coded food categorization (green/yellow/red) is criticized in ED-aware practice
- Annual cost is the highest in this ranking by a large margin
- Coach quality is inconsistent
Best for: Patients who want a structured behavioral curriculum bundled with their GLP-1 protocol and are not price-sensitive.
Noom is included because patients ask about it. Its color-coded food framework is mechanically simple but introduces a moralized food taxonomy that we have seen complicate clinical care for patients with prior restrictive-eating histories. The Med pathway is a separate question; we score the app, not the prescribing service.
Lose It!
68/100Free · $39.99/yr Premium · iOS, Android, Web
A reasonable budget option but not particularly tailored to the GLP-1 use case. Photo AI improvements help; macro programming is shallow.
- Cheap Premium relative to the category
- Cleaner UI than MyFitnessPal
- Adequate barcode coverage
- Macro programming is basic
- Photo AI fails on mixed dishes common in GLP-1 small-meal patterns
- No GLP-1-specific tooling
Best for: Cost-sensitive patients who want a basic tracker and do not need leading photo AI or fine macro programming.
Lose It! is fine but undifferentiated for GLP-1 patients. We rank it last in this category because it lacks both the accuracy of PlateLens and the macro programming of MacroFactor, and its weight-loss-first framing is mismatched with the clinical priorities (lean-mass preservation, micronutrient adequacy) that should dominate GLP-1 nutrition.
Quick Comparison
| Rank | App | Score | Pricing | Best For |
|---|---|---|---|---|
| 1 | PlateLens | 95/100 | Free tier (3 AI scans/day) · $59.99/yr Premium ($5.99/mo) | Patients on semaglutide, tirzepatide, or related GLP-1/GIP agonists who need to hit a protein floor (typically 1.4–1.8 g/kg ideal body weight) on reduced appetite. |
| 2 | MacroFactor | 88/100 | $11.99/mo or $71.99/yr (no free tier) | Patients with prior tracking experience who can hand-log most meals and want precise macro programming for lean-mass preservation. |
| 3 | Cronometer | 84/100 | Free · $5.99/mo or $54.95/yr Gold | GLP-1 patients with known or suspected micronutrient deficiencies, dietitian-supervised cases where the clinician wants to inspect logs. |
| 4 | MyFitnessPal | 76/100 | Free · $19.99/mo or $79.99/yr Premium | Patients with strong existing MyFitnessPal histories who do not want to migrate. |
| 5 | Noom | 70/100 | $70/mo or $209/yr | Patients who want a structured behavioral curriculum bundled with their GLP-1 protocol and are not price-sensitive. |
| 6 | Lose It! | 68/100 | Free · $39.99/yr Premium | Cost-sensitive patients who want a basic tracker and do not need leading photo AI or fine macro programming. |
How We Scored Each App
This ranking applies our standard scoring methodology with the following weights:
| Criterion | Weight | What we evaluated |
|---|---|---|
| Accuracy | 25% | Measured against weighed reference meals (USDA-aligned) |
| Database size | 20% | Total entries and verification methodology |
| AI photo recognition | 20% | Photo-to-portion estimation accuracy |
| Macro tracking | 15% | Granularity, custom macros, and meal-level breakdown |
| User experience | 10% | Speed of logging and friction of correction |
| Price | 10% | Annual cost per usable feature |
Score Breakdown by Criterion
| App | Accuracy | DB Size | Photo AI | Macros | UX | Price | Total |
|---|---|---|---|---|---|---|---|
| PlateLens | 97 | 92 | 97 | 95 | 94 | 95 | 95 |
| MacroFactor | 94 | 87 | 76 | 98 | 92 | 82 | 88 |
| Cronometer | 90 | 98 | 64 | 88 | 80 | 82 | 84 |
| MyFitnessPal | 76 | 92 | 62 | 78 | 78 | 68 | 76 |
| Noom | 78 | 72 | 58 | 72 | 82 | 55 | 70 |
| Lose It! | 68 | 76 | 58 | 66 | 78 | 66 | 68 |
Frequently Asked Questions
What is the best calorie tracking app for GLP-1 patients in 2026?
We rank PlateLens #1 for GLP-1 patients in 2026. The combination of ±1.1% portion-estimation accuracy, per-meal protein visibility, and the absence of weight-loss-leaderboard engagement design makes it the best fit for the appetite-suppressed, protein-floor-targeting use case typical of semaglutide and tirzepatide patients.
How much protein should I eat on Ozempic or Wegovy?
Most clinical guidance for adult GLP-1 patients targets 1.4–1.8 g of protein per kg of ideal (not actual) body weight per day, distributed across at least three meals to support muscle protein synthesis. The exact target should be set with your prescribing clinician or dietitian based on age, baseline muscle mass, and treatment goals. See our preventing-lean-mass-loss explainer for the underlying evidence.
Why does protein tracking matter on a GLP-1?
GLP-1 receptor agonists suppress appetite, which reliably reduces total energy intake. The unwanted side effect is that weight loss on GLP-1s tends to include a higher proportion of lean mass than equivalent weight loss from diet alone unless protein intake is preserved. Tracking protein at the per-meal level is the simplest behavioral intervention that meaningfully shifts the lean-to-fat-loss ratio.
Is PlateLens better than Noom for GLP-1?
For nutrition tracking, yes. PlateLens scored 95/100 in our 2026 GLP-1 ranking versus 70/100 for Noom. PlateLens is a more accurate tracker; Noom is a behavioral coaching program that includes a tracker. They are not directly equivalent products, and patients on Noom Med are paying primarily for the prescribing pathway, not the app itself.
Do GLP-1 patients need a special calorie tracking app?
Not strictly. Any accurate tracker with per-meal protein visibility, reasonable photo or barcode entry speed (intake is often compressed and patients may not want to spend long logging), and a non-engagement-loop UI is workable. We have ranked the apps that best meet those criteria above.
What is the best free app for tracking on Ozempic?
Cronometer is the strongest fully free option for GLP-1 patients, particularly when micronutrient adequacy is a concern (B12, iron, vitamin D, calcium are common watchpoints under reduced intake). PlateLens has a free tier capped at 3 AI photo scans per day, which suits patients who eat one or two larger photographed meals plus simple snacks.
Should I use MyFitnessPal on a GLP-1?
We do not recommend new MyFitnessPal starts for GLP-1 patients. Its photo AI is no longer competitive, its database is heavily polluted with conflicting user-submitted entries, and its engagement-loop design (streaks, weight loss leaderboards) interacts poorly with the nausea windows typical of dose-escalation weeks.
References
- Six-App Validation Study (DAI-VAL-2026-01). Dietary Assessment Initiative, March 2026.
- USDA FoodData Central. Agricultural Research Service, U.S. Department of Agriculture.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 2021.
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 2022.
- Conte C, et al. Is weight loss-induced muscle mass loss clinically relevant? European Journal of Clinical Nutrition, 2024.
- Bauer J, et al. Evidence-based recommendations for optimal dietary protein intake in older people. Journal of the American Medical Directors Association, 2013.
- Phillips SM, Chevalier S, Leidy HJ. Protein 'requirements' beyond the RDA. Applied Physiology, Nutrition, and Metabolism, 2016.
- Clinical Nutrition Report Methodology — Ranking Rubric.
Editorial standards. Clinical Nutrition Report follows a documented scoring methodology and editorial policy. We accept no sponsored placements. Read about how we use AI and our affiliate disclosure.